Table 2.
Relationship between MYBL1 expression level and clinicopathological variables and in pancreatic cancer patients
| Clinical features | Characteristic | MYBL1 high expression group | MYBL1 low expression group | P_value |
|---|---|---|---|---|
| Status | Alive | 42 | 44 | |
| Dead | 48 | 45 | 0.825 | |
| Age | Mean (SD) | 64 (10.6) | 65.2 (11.3) | |
| Median [MIN, MAX] | 64 [40,88] | 66 [35,85] | 0.442 | |
| Gender | FEMALE | 43 | 37 | |
| MALE | 47 | 52 | 0.494 | |
| Race | ASIAN | 2 | 9 | |
| BLACK | 5 | 1 | ||
| WHITE | 81 | 77 | 0.027 | |
| new_tumor_event_type | Metastasis | 34 | 24 | |
| Metastasis:Recurrence | 2 | |||
| Recurrence | 9 | 11 | ||
| Primary | 2 | 0.426 | ||
| Smoking | Non-smoking | 32 | 34 | |
| Smoking | 37 | 42 | 0.975 | |
| Radiation_therapy | Non-radiation | 50 | 53 | |
| Radiation | 15 | 17 | 1 | |
| History_of_neoadjuvant_treatment | No neoadjuvant | 90 | 88 | |
| Yes, Radiation Prior to Resection | 1 | |||
| Therapy_type | Ancillary:Chemotherapy | 9 | 5 | |
| Chemotherapy | 51 | 51 | ||
| Chemotherapy:Hormone Therapy | 1 | |||
| Chemotherapy:Vaccine | 1 | 0.473 |
* The absence of clinical data for certain samples resulted in a diminished sample size of cases exhibiting specific individual clinical characteristics, amounting to fewer than 179 instances.